Overview

• US fertility clinic operator's FY2025 revenue grew 5% yr/yr

• Net loss from continuing operations narrowed to $5.3 mln from $7.7 mln

• Company closed Indiana clinic acquisition and expanded employer-benefit access

Outlook

• Company says it is focused on driving organic growth across existing clinics and integrating acquisitions

• INVO Fertility expects favorable long-term demand trends and expanding employer-benefit coverage to support growth

• Company says it has a robust acquisition pipeline and improved balance sheet to support future expansion

Result Drivers

• CLINIC ACQUISITION - Co said revenue growth was supported by the acquisition of Indiana-based Family Beginnings clinic in February 2026

• EMPLOYER-BENEFIT ACCESS - Wisconsin Fertility Institute joined the Progyny network, broadening access to employer-sponsored patients and strengthening payor mix

• ORGANIC GROWTH INITIATIVES - New initiatives at Atlanta clinic since March 2026 are having meaningful impact, per company

Company press release: ID:nGNX76j8Hk

Key Details

Metric	Beat/Miss	Actual	Consensus Estimate
Q1 Revenue		$6.84 mln

Analyst Coverage

• The one available analyst rating on the shares is "buy"

• The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy"

• Wall Street's median 12-month price target for INVO Fertility Inc is $20.00, about 1,260.5% above its June 1 closing price of $1.47

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.